VAERS Explorer
Back to explore

Report #2837370

Received Apr 22, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
20 yrs
State
TX
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
MMRMEASLES + MUMPS + RUBELLA (PRIORIX)GLAXOSMITHKLINE BIOLOGICALSUNK—IM

Symptoms (1)

Incorrect route of product administration

Symptom narrative

A 20 years old female patient received a dose of Priorix IM instead of SQ; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of subcutaneous injection formulation administered by other route in a 20-year-old female patient who received MMR (Priorix) for prophylaxis. On an unknown date, the patient received Priorix (intramuscular). On an unknown date, an unknown time after receiving Priorix, the patient experienced subcutaneous injection formulation administered by other route (Verbatim: A 20 years old female patient received a dose of Priorix IM instead of SQ). The outcome of the subcutaneous injection formulation administered by other route was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 17-APR-2025 Other HCP reported that a patient received Priorix intramuscularly instead of subcutaneously, which led to subcutaneous injection formulation administered by other route. Reporter asked does it need a revaccination or not. Also asked what do they have to do next.